Excitatory amino acid receptors in epilepsy

https://doi.org/10.1016/0165-6147(90)90238-4Get rights and content

Abstract

Excitatory amino acid transmitters participate in normal synaptic transmission throughout the CNS (see Headley and Grillner, May TiPS), so it comes as no surprise that such excitatory pathways are involved in the initiation of seizures and their propagation. Most attention has been directed to synapses using NMDA receptors, although more recent evidence indicates potential roles for the AMPA receptors as well. In this article — the first of two to focus on the neurological dangers inherent in excitatory amino acid pathways — Raymond Dingledine, Chris McBain and James McNamara consider their involvement in epilepsy; next month's article will cover brain damage following ischemia and hypoxia.

References (35)

  • C.J. McBain et al.

    Neurosci. Lett.

    (1988)
  • S.F. Stasheff et al.

    Brain Res.

    (1985)
  • N.T. Slater et al.

    Neurosci. Lett

    (1985)
  • J.O. McNamara et al.

    Neuropharmacology

    (1988)
  • A. Vezzani et al.

    Neurosci. Lett.

    (1988)
  • K. Sato et al.

    Brain Res.

    (1988)
  • M.J. Croucher et al.

    Eur. J. Pharmacol.

    (1988)
  • D.W. Peterson et al.

    Brain Res.

    (1983)
  • R.A. Morrisett et al.

    Brain Res.

    (1989)
  • P.J. Birch et al.

    Eur. J. Pharmacol.

    (1988)
  • M.D. Tricklebank et al.

    Eur. J. Pharmacol.

    (1989)
  • B.W.M.M. Peeters et al.

    Epilepsy Res.

    (1989)
  • A.G. Chapman et al.

    Eur. J. Pharmacol.

    (1989)
  • E.J. Furshpan et al.

    Neuron

    (1989)
  • C.W. Cotman et al.

    Trends Neurosci.

    (1987)
  • J.A. Aram

    Br. J. Pharmacol.

    (1989)
  • N.W. Kleckner et al.

    Mol. Pharmacol.

    (1989)
  • Cited by (427)

    • Alpha-pinene and dizocilpine (MK-801) attenuate kindling development and astrocytosis in an experimental mouse model of epilepsy

      2020, IBRO Reports
      Citation Excerpt :

      MK-801 effectively reduced seizure severity and reduced mortality in PTZ kindling mice. Several studies have shown that NMDA receptor antagonists delay kindling acquisition and prevent the onset of seizures (Dingledine et al., 1990). In this study, α-pinene suppressed kindling acquisition by preventing an increase in seizures by PTZ.

    • Levetiracetam mediates subtle pH-shifts in adult human neocortical pyramidal cells via an inhibition of the bicarbonate-driven neuronal pH-regulation – Implications for excitability and plasticity modulation

      2019, Brain Research
      Citation Excerpt :

      Both, the potassium-mediated depolarization and the AMPA-induced intracellular alkalizations relied upon NBCs-activity (Svichar et al., 2011). In this context, LEV would have the potency to work quite selectively anticonvulsive in the alkaline states of epileptic neurons, themselves characterized by frequent and rhythmic paroxysmal depolarization shifts in intracellular recordings (Dingledine et al., 1990) which may precipitate such alkaline states (Svichar et al., 2011). Considering LEV’s dynamic pHi-modulation depending on the resting pHi (Fig. 1), the anticonvulsive power of LEV would be amplified by the severity of the regional epileptic activity, that means, the extend of the EDIA (Fig. 6).

    • Glutamatergic NMDA Receptor as Therapeutic Target for Depression

      2016, Advances in Protein Chemistry and Structural Biology
      Citation Excerpt :

      Excessive excitation of glutamate receptors can cause neuronal damage or death; this process is called excitotoxicity (Olney & de Gubareff, 1978; Olney, Labruyere, & de Gubareff, 1980). Excitotoxicity is associated with ischemic neuronal injury (Choi & Rothman, 1990; Olney, 1990), acute neurodegenerative disorders such as epilepsy (Dingledine, McBain, & McNamara, 1990; Price, 1999), chronic neurodegenerative diseases such as Alzheimer's disease and Huntington's disease, hepatic encephalopathy (Beal et al., 1986; Lipton & Rosenberg, 1994; Price, 1999), genetic diseases (Dingledine et al., 1990; Meldrum & Garthwaite, 1990), and mood disorders (Ghasemi et al., 2014). Relatively, the brain possesses a lot of glutamate (approximately 5–15 nmol/kg, depending on the region) and only a small fraction of this total accumulates in the extracellular space (Danbolt, 2001).

    View all citing articles on Scopus
    View full text